Infusion and continual care administration firm Uptiv Well being introduced a partnership with the automation platform Lamar Well being to implement AI-powered automation for referral consumption and prior authorization processes.
Uptiv provides infusion remedy for sufferers with continual circumstances through a hybrid mannequin that merges personalized in-clinic care with a digital platform.
Along with conventional infusion companies, Uptiv supplies care coordination, psychological well being teaching and different whole-person care companies.
Lamar Well being supplies an AI-powered automation platform aimed particularly at specialty medicine workflows.
The corporate was based by Stanford Medication, McKesson and CoverMyMeds, and it’s backed by Y Combinator and PennyJar Capital, Wholesome VC, Flex Capital, Dnipro VC and Shah Capital.
Lamar’s platform connects to main EHR techniques and learns to enhance authorization processes.
The partnership goals to combine Lamar Well being’s specialty medication-focused AI platform into Uptiv Well being’s operations to streamline administrative workflows and cut back the time to therapy for sufferers with continual circumstances.
Lamar Well being’s AI platform automates complicated administrative duties within the prior authorization course of, which the corporate says has sometimes been laborious and topic to delays.
The intention is to reduce the authorization timeline and permit sufferers to begin therapy sooner, lower labor prices linked to consumption and prior authorization processes, redistribute workers time from paperwork to affected person interactions, enhance the time from referral to therapy, and facilitate connecting with EHRs to take away pointless information entry and documentation.
“Our partnership with Lamar Well being permits us to allocate sources away from administrative burdens and towards creating distinctive affected person experiences that set us aside within the market,” Torben Nielsen, CEO of Uptiv Well being, mentioned in an announcement.
THE LARGER TREND
In 2024, Uptiv Well being partnered with Lyn Well being to merge infusion remedy with continual care administration via an providing dubbed Uptiv360. By the partnership, sufferers bear an onboarding course of through an app, adopted by an analysis by a nurse practitioner throughout an infusion go to.
Inside 48 hours, sufferers are linked with a Lyn Well being care workforce to entry digital continual care administration care, together with behavioral well being companies.
Additionally final yr, Uptiv Well being opened an infusion heart in Troy, Michigan.
The middle collaborates with referring physicians, hospital techniques and payers to supply seamless and accessible take care of infusion sufferers with continual circumstances, together with a number of sclerosis, Crohn’s illness, colitis, rheumatoid arthritis, lupus, extreme bronchial asthma and allergy symptoms.
Uptiv launched in 2023 with $7.5 million in seed funding, alongside the opening of its flagship infusion heart in Westland, Michigan.